PT Bundamedik Tbk (ISX:BMHS) Shares Outstanding (EOP): 8,603 Mil (As of Mar. 2026)


ISX:BMHS PT Bundamedik Tbk ISX:BMHS
61 GF Score
Price Rp175.00
GF Value Rp306.91
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is PT Bundamedik Tbk Shares Outstanding (EOP)?

PT Bundamedik Tbk ISX:BMHS +1.16% 61 Shares Outstanding (EOP) is 8,603 Mil as of Mar. 2026. GuruFocus rates ISX:BMHS with a GF Score™ of 61/100 and a GF Value™ of Rp306.91 (Possible Value Trap). The stock has 4 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. PT Bundamedik Tbk's shares outstanding for the quarter that ended in Mar. 2026 was 8,603 Mil.

PT Bundamedik Tbk's quarterly shares outstanding stayed the same from Dec. 2025 (8,603 Mil) to Mar. 2026 (8,603 Mil).

PT Bundamedik Tbk's annual shares outstanding stayed the same from Dec. 2024 (8,603 Mil) to Dec. 2025 (8,603 Mil).


PT Bundamedik Tbk  (ISX:BMHS) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


PT Bundamedik Tbk Shares Outstanding (EOP) Related Terms


PT Bundamedik Tbk Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for PT Bundamedik Tbk's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Bundamedik Tbk Shares Outstanding (EOP) Chart

PT Bundamedik Tbk Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial 8,603.42 8,603.42 8,603.42 8,603.42 8,603.42

PT Bundamedik Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,603.42 8,603.42 8,603.42 8,603.42 8,603.42

ISX:BMHS vs HCA, THC, DVA: Shares Outstanding (EOP) Comparison

For the Medical Care Facilities subindustry, PT Bundamedik Tbk's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PT Bundamedik Tbk Shares Outstanding (EOP) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PT Bundamedik Tbk's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where PT Bundamedik Tbk's Shares Outstanding (EOP) falls into.


ISX:BMHS
61GF Score
PT Bundamedik Tbk ISX:BMHS
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Bundamedik Tbk Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 8,603 Mil mean?
PT Bundamedik Tbk (ISX:BMHS) has a Shares Outstanding (EOP) of 8,603 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on PT Bundamedik Tbk and its competitors.
Is PT Bundamedik Tbk's Shares Outstanding (EOP) too high?
PT Bundamedik Tbk's current Shares Outstanding (EOP) is 8,603 Mil. Overall, PT Bundamedik Tbk has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Bundamedik Tbk's Shares Outstanding (EOP) compare to HCA and THC?
PT Bundamedik Tbk's Shares Outstanding (EOP) of 8,603 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Healthcare Providers & Services company?
A good Shares Outstanding (EOP) depends on the Healthcare Providers & Services industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on PT Bundamedik Tbk and its competitors. PT Bundamedik Tbk's current Shares Outstanding (EOP) is 8,603 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Bundamedik Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Bundamedik Tbk (ISX:BMHS) is currently considered Possible Value Trap. The stock's GF Value™ is Rp306.91, compared to a current price of Rp175.00 — trading 43% below its estimated fair value. The current Shares Outstanding (EOP) is 8,603 Mil. PT Bundamedik Tbk's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For PT Bundamedik Tbk (ISX:BMHS), the current Shares Outstanding (EOP) is 8,603 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Bundamedik Tbk (ISX:BMHS) Overvalued in 2026?

Based on GuruFocus' analysis, PT Bundamedik Tbk stock appears to be undervalued. The current stock price of Rp175.00 is trading 43% below its estimated GF Value™ of Rp306.91. GuruFocus considers PT Bundamedik Tbk to be Possible Value Trap.

Key valuation signals for ISX:BMHS:

  • Shares Outstanding (EOP): 8,603 Mil
  • GF Value™: Rp306.91 vs. price of Rp175.00 (43% below fair value)
  • GF Score™: 61/100 with 4 warning signs

No single metric tells the full story. See the ISX:BMHS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Bundamedik Tbk Business Description

Address Jalan Teuku Cik Ditiro No.28, Menteng, Jakarta Pusat, IDN, 10350
PT Bundamedik Tbk is a healthcare service provider. The Company carries out its main business activities through private hospital activities. It offers maternal and child health services, outpatient services, inpatient services, emergency services, service excellence centers, IVF services, and Clinical laboratory services.
61GF Score

Get the complete analysis for ISX:BMHS

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp175.00
Price
Rp306.91
GF Value